Cas:1072946-45-2 (4-(Aminomethyl)-3-fluorophenyl)boronic acid hydrochloride manufacturer & supplier

Chemical Name:(4-(Aminomethyl)-3-fluorophenyl)boronic acid hydrochloride

CAS.NO:1072946-45-2

Synonyms:[2-(Aminomethyl)-5-fluorophenyl]boronic acid hydrochloride (1:1);Boronic acid, B-[4-(aminomethyl)-3-fluorophenyl]-, hydrochloride (1:1);x1548;[4-(Aminomethyl)-3-fluorophenyl]boronic acid hydrochloride (1:1);i04-6523;a-3732;Boronic acid, B-[2-(aminomethyl)-5-fluorophenyl]-, hydrochloride (1:1)

Molecular Formula:C₇H₁₀BClFNO₂

Molecular Weight:205.422

HS Code:2931900090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:66.48000

Exact Mass:205.047714

LogP:0.46650

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like [2-(Aminomethyl)-5-fluorophenyl]boronic acid hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Boronic acid, B-[2-(aminomethyl)-5-fluorophenyl]-, hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,x1548 Use and application,i04-6523 technical grade,usp/ep/jp grade.

Related News: In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. (4-(Aminomethyl)-3-fluorophenyl)boronic acid hydrochloride manufacturer The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward. (4-(Aminomethyl)-3-fluorophenyl)boronic acid hydrochloride supplier But the ban from Italy remains, Joseph Wu, Taiwan��s foreign minister, said on Sunday. (4-(Aminomethyl)-3-fluorophenyl)boronic acid hydrochloride vendor After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. (4-(Aminomethyl)-3-fluorophenyl)boronic acid hydrochloride factory Roche’s second anti-tau antibody UCB0107, partnered with UCB, is also slated to enter deeper testing this year. Tau had appeared to have fresh promise as a rival of sorts to amyloid. Tau theory goes that neurofibrillary tangles that form inside cells clog up the brain, and clearing this can help Alzheimer’s patients.